IL33 and asthma: In the context of IL-33-induced asthma, we found that mice lacking ICAM-1 developed lower AHR and lung inflammation, and confirmed our results using a clinically proven anti-ICAM-1 blocking antibody in Rag−/− mice (Supplementary Figure 4).